翰思艾泰生物医药科技（武汉）股份有限公司（股票代码：03378）4月24日公告，已于香港联交所场内回购36,300股股份，占回购前公司已发行股本约0.0267%。每股回购价格介乎28.00港元至31.36港元，合计涉资约105.77万港元。
本次回购完成后，已发行股本为135,878,330股，库藏股数为340,500股，总股本规模保持在136,218,830股。公司于2026年2月12日通过购回授权，获准回购的总数为13,621,883股。截至公告日，已累计回购340,500股，占授权通过当日公司已发行股本的0.25%。
公司确认已遵守香港联交所证券上市规则及相关法律法规。公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.